Digestive System Neoplasms Clinical Trials

A listing of Digestive System Neoplasms medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Scottsdale Arizona 85259

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating Minnelide™ 001 for the treatment of Advanced Gastrointestinal Tumors

California

La Jolla California 92093-0956

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Los Angeles California 90095

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Los Angeles California 90033

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Newport Beach California 92663

A clinical trial to evaluate treatments using Stool Sample Collection Kit for patients with Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases or Colorectal Cancer

Sacramento California 95817

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

San Francisco California 9411

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Santa Monica California 90404

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Colorado

Aurora Colorado 80045

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Denver Colorado 80218

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Connecticut

Hamden Connecticut 06518

A clinical trial to evaluate treatments using Stool Sample Collection Kit for patients with Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases or Colorectal Cancer

New Haven Connecticut 06519

A clinical trial to evaluate treatments using Sorafenib, Capecitabine for patients with Metastatic Breast Cancer or Gastrointestinal Tumors

New Haven Connecticut 06510

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Florida

Boca Raton Florida 33486

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Fort Myers Florida 33916

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gainesville Florida 32610

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gainesville Florida 32605

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Miami Florida 33136

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Miami Florida 33136

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Orlando Florida 32803

A clinical trial to evaluate treatments using Stool Sample Collection Kit for patients with Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases or Colorectal Cancer

Orlando Florida 32804

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Georgia

Atlanta Georgia 30341

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Illinois

Chicago Illinois 60612

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Chicago Illinois 60637

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Chicago Illinois 60612

A clinical trial to evaluate treatments using Stool Sample Collection Kit for patients with Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases or Colorectal Cancer

Chicago Illinois 60637

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chicago Illinois 60612

Patients are needed to participate in a clinical research study evaluating Alisertib and Pazopanib for the treatment of Solid Tumor or Advanced Non-hematologic Solid Tumor

Evanston Illinois 60201

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Niles Illinois 60714

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Indiana

Goshen Indiana 46526

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Lafayette Indiana 47905

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Muncie Indiana 47303

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Iowa

Iowa City Iowa

A clinical research study of [68Ga]MLN6907 for the treatment of Imaging of Solid Gastrointestinal Tumors

Kentucky

Louisville Kentucky 40202

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Louisiana

Metairie Louisiana 70006

A clinical trial to evaluate treatments using Stool Sample Collection Kit for patients with Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases or Colorectal Cancer

New Orleans Louisiana 70121-2483

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Shreveport Louisiana 71103

A clinical trial to evaluate treatments using Stool Sample Collection Kit for patients with Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases or Colorectal Cancer

Maryland

Chevy Chase Maryland 20815

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Chevy Chase Maryland 20815

A clinical trial to evaluate treatments using Stool Sample Collection Kit for patients with Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases or Colorectal Cancer

Massachusetts

Boston Massachusetts 02118

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Boston Massachusetts 02114

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Boston Massachusetts 02114

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston Massachusetts 02215

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston Massachusetts 02115

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Brockton Massachusetts 02302

A clinical trial to evaluate treatments using Stool Sample Collection Kit for patients with Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases or Colorectal Cancer

Michigan

Ann Arbor Michigan 48109

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Detroit Michigan 48201

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2